End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | -99.96% |
Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
Mar. 25 | Infinity Pharmaceuticals, Inc. Went Out of Business | CI |
Financials (USD)
Sales 2021 | 1.86M | Sales 2022 | 2.59M | Capitalization | 49.59M |
---|---|---|---|---|---|
Net income 2021 | -45M | Net income 2022 | -44M | EV / Sales 2021 | 91.8 x |
Net cash position 2021 | 29.67M | Net Debt 2022 | 11.04M | EV / Sales 2022 | 23.4 x |
P/E ratio 2021 |
-4.25
x | P/E ratio 2022 |
-1.11
x | Employees | 30 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.27% |
3 months | -99.00% | ||
6 months | -99.97% | ||
Current year | -99.96% |
Managers | Title | Age | Since |
---|---|---|---|
Seth Tasker
CEO | Chief Executive Officer | 45 | 08-02-29 |
Jennifer Roberts
PRN | Corporate Officer/Principal | - | 17-09-30 |
Melissa Hackel
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Evnin
BRD | Director/Board Member | 83 | 06-08-31 |
Norman Selby
BRD | Director/Board Member | 71 | 12-03-11 |
David W. Beier
BRD | Director/Board Member | 75 | 18-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.000001 | 0.00% | 1,350 |
24-04-22 | 0.000001 | 0.00% | 100 |
End-of-day quote OTC Markets, April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-99.96% | 90 | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- INFI.Q Stock